Government of Canada and partners invested $18 million in crucial microbiome research
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
Ontario Institute for Cancer Research leukemia therapy discovery received approximately $1 billion in funding from Celgene
On Jan. 29, 2019, Ontario Institute for Cancer Research’s (OICR) Drug Discovery Program’s first-of-its-kind leukemia therapy discovery received…
deCODE published the first full resolution genetic map of the human genome
On Jan. 24, 2019, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published the first genetic…
Karmanos Cancer Institute awarded President’s Trophy by McLaren Health Care system
On Jan. 24, 2019, the Barbara Ann Karmanos Institute received the President’s Trophy from McLaren Health Care system,…
Pascal Biosciences commenced cannabinoid testing of human volunteers and patients
On Jan. 24, 2019, Pascal Biosciences announced the testing of cannabinoids in human subjects for its immune stimulatory…
FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…
TESARO was acquired by GSK for $5.1 billion
On Jan. 22, 2019, GlaxoSmithKline acquired TESARO based in Waltham, Massachusetts, for an aggregate cash consideration of approximately…
Masonic Cancer Center researcher Branden Moriarity, PhD, received U24 Grant with Recombinetics, Inc
On Jan. 18, 2019, Masonic Cancer Center researcher Branden Moriarity, PhD, received a U24 Grant with Recombinetics. The…
FDA approved Vaxelis, a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks-4 yrs of age
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
The Allen Institute for Immunology was founded
On Dec. 12, 2018, the Allen Institute announced the launch of the Allen Institute for Immunology, a new…
A UCLA-led research team identified genetic processes involved in the neurodegeneration that occurs in dementiaï¾
On Dec 3, 2018, a University of California, Los Angeles (UCLA) led research team announced they had identified…
FDA approved gilteritinib, a targeted drug for leukemia tested at UPenn
On Nov. 28, 2018, The U.S. Food and Drug Administration (FDA) announced it had approved the first ever…
Canadian Cancer Trials Group announced IND.234 clinical trial using liquid biopsy technology for prostrate cancer screening
On Nov. 27, 2018, the Canadian Cancer Trials Group announced the IND.234 clinical trial, the first of its…
The Abramson Cancer Center joined the National Comprehensive Cancer Network as its 28th member institution
On Nov. 20, 2018, the Abramson Cancer Center joined the National Comprehensive Cancer Networkï¾® (NCCN) as its 28th…
Pascal Biosciences announced optimization of cannabinoid-derived drug candidates to kill glioblastoma cells
On Nov. 15, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
Biotechnology | CDC | Disease | Life Science News | Vaccine
ACIP published updated recommendations on use of hepatitis A vaccine for pre- and post-exposure prophylaxis for international travel
On Nov. 2, 2018, the Immunization Practices Advisory Committee (ACIP) published updated recommendations on use of hepatitis A…
AcelRx pharmaceutical DSUVIA was approved by FDA
On Nov. 2, 2018, AcelRx pharmaceutical’s DSUVIA was approved by U.S. Food and Drug Administration (FDA). DSUVIA is…
The Earth BioGenome Project was founded
On Nov. 1, 2018, the Earth BioGenome Project (EBP) was launched, a global effort to sequence the genetic…
Biotechnology | Disease | Life Science History | Life Science News | Non-Profit Research | Therapeutics
City of Hope, TGen announced letter of intent to build cell therapy manufacturing facility in Phoenix area
On Nov. 1, 2018, City of Hope, and its affiliate, Translational Genomics Research Institute (TGen), announced a letter…
Pascal Biosciences and the University of Washington announced exclusive license agreement to develop cannabinoid-based medicine for cancer
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
FNIH Biomarkers Consortium and Critical Path Institute achieve qualification of a clinical safety biomarker
On Oct. 25, 2018, The Foundation for the National Institutes of Health, Biomarkers Consortium and the Critical Path…
The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors
On Oct. 22, 2018, the National Cancer Institute awarded a $10.7 million five year grant to Abramson Cancer…
Siteman Cancer Center to offer newest form of proton therapy
On Oct. 22, 2018, the Siteman Cancer Center announced a second proton therapy system that would incorporate pencil-beam…
Genomic analysis offered insight into 2018 Nigeria Lassa fever outbreak
On Oct. 18, 2018, an international team of researchers reported that a surge in Lassa fever cases in…
Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny
On Oct. 16, 2018, Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny to…
FDA approved expanded use of Gardasil 9 vaccine to include adults 27 through 45 years old
On Oct. 5, 2018, the FDA announced it had approved a supplemental application for Gardasil 9 (Human Papillomavirus…
Frances H. Arnold won a share of the Nobel Prize in Chemistry for the directied evolution of enzymes
On Oct. 3, 2018, the Nobel Foundation announced that Frances H. Arnold had won a share of the…
CPRIT researcher James P Allison was awarded the 2018 Nobel Prize in physiology or medicine jointly with Tasuku Honjo
On Oct. 1, 2018, James P. Allison, a native of Alice, Texas, son of a country doctor, and…
Researchers at JCVI, UCSD, and Scripps Oceanography discovered genetic basis for how harmful algal blooms become toxic
On Sept. 27, 2018, Researchers from Scripps Institution of Oceanography at UCSD and the J. Craig Venter Institute…
Vaccitech licensed MERS rights to Oxford University
On Sept. 27, 2018, CEPI (the Coalition for Epidemic Preparedness Innovations) announced a collaboration with The Jenner Institute…